Pfizer India Overview
- Founded
-
1950
- Status
-
Public
- Employees
-
2,358
- Stock Symbol
-
PFIZER
- Investments
-
3
- Share Price
-
$53.03
- (As of Friday Closing)
Pfizer India General Information
Description
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its to segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. Most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NSE
Primary Office
- The Capital, 1802, 18th Floor, Plot Number C-70, 'G' Block Bandra Kurla Complex
- Bandra East
- Mumbai, Maharashtra 400051
- India
+91 022 0000 0000
Pfizer India Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $53.03 | $53.09 | $51.22 - $84.06 | $2.43B | 45.7M | 18.6K | $1.29 |
Pfizer India Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 2,171,317 | 2,428,684 | 2,683,397 | 2,149,253 |
| Revenue | 325,701 | 350,374 | 300,865 | 302,814 |
| EBITDA | 82,942 | 114,007 | 101,411 | 88,253 |
| Net Income | 59,081 | 82,214 | 66,883 | 71,658 |
| Total Assets | 514,387 | 444,668 | 584,116 | |
| Total Debt | 0 | 22,022 | 14,420 | 16,962 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Pfizer India Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pfizer India Patents
Pfizer India Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210045233-A1 | Component carrier and method of manufacturing the same | Granted | 08-Aug-2019 | 000000000000 | |
| DE-102020120491-A1 | Component carrier and method of making the same | Pending | 08-Aug-2019 | 000000000000 | |
| US-11350520-B2 | Component carrier and method of manufacturing the same | Active | 08-Aug-2019 | 0000000000 | 00 |
| EP-3386983-A1 | 4-(biphen-3-yl)-1h-pyrazolo[3,4-c]pyridazine derivatives of formula (i) as gaba receptor modulators for use in the treatment of epilepsy and pain | Withdrawn | 10-Dec-2015 | 0000000000 | |
| CA-3007595-A1 | 4-(biphen-3-yl)-1h-pyrazolo[3,4-c]pyridazine derivatives of formula (i) as gaba receptor modulators for use in the treatment of epilepsy and pain | Granted | 10-Dec-2015 | C07D487/04 |
Pfizer India Executive Team (7)
Pfizer India Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 000000 | Self | Board Member | 000 0000 |
| 000000 00000 | Pfizer India | Chief Financial Officer, Finance & Board Member | 000 0000 |
| 000000 0000 | Pfizer India | Chairman & Board Member | 000 0000 |
| 0. 0000000 | Pfizer India | Country Manager, Board Member & Managing Director | 000 0000 |
| 00000000000 0000000 | Pfizer India | Board Member & Managing Director | 000 0000 |
Pfizer India Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Pfizer India Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 22-Sep-2021 | 0000 00000 | 00000 | Other Healthcare Technology Systems | |
| 00000000000 ( | 31-May-2017 | 000000000 | 000.00 | Buildings and Property | 0. 000000 |
| Valetude Primus Healthcare | 01-Jan-2016 | Accelerator/Incubator | 000.00 | Diagnostic Equipment |